Dosimetry in <sup>177</sup>Lu-PRRT for Neuroendocrine Tumors: Current Concepts, Clinical Relevance and Future Perspectives. [PDF]
Poniatowska-Roszkowska ME +3 more
europepmc +1 more source
Towards practical radiopharmaceutical treatment planning: a review of dosimetry simplification techniques. [PDF]
Yazdani E +3 more
europepmc +1 more source
Advances in Transarterial Radionuclide Therapy for Hepatocellular Carcinoma and Other Liver Tumors: From Yttrium-90 Radioembolization to Emerging Lipiodol-Based Theranostic Approaches. [PDF]
Kono Y +3 more
europepmc +1 more source
Theranostics in Radiation Medicine: Integrating Radiopharmaceutical Therapy and External-Beam Radiotherapy. [PDF]
Srinivasan S, Moore JA, Han-Oh S.
europepmc +1 more source
Estimation of effective half-life and lesion-specific kinetics in I-131 therapy for differentiated thyroid cancer using dual-timepoint imaging. [PDF]
Iizuka Y +8 more
europepmc +1 more source
Artificial intelligence-assisted photodynamic diagnosis and photodynamic therapy against cancer. [PDF]
Huang J, Law SK, Leung AWN, Xu C.
europepmc +1 more source
Design and validation of a deep learning GAN for predicting <sup>1</sup> <sup>7</sup> <sup>7</sup>Lu dose voxel kernels using GATE/GEANT4 Monte Carlo and IDAC-Dose 2.1 in phantom dosimetry. [PDF]
Kapis OE +3 more
europepmc +1 more source
The next evolution of theranostics: from target discovery to integrated precision medicine. [PDF]
Montemagno C, Serrano B, Paulmier B.
europepmc +1 more source
Expanding our knowledge of internal dosimetry - lung dosimetry.
openaire +1 more source

